Tebu Bio
Life sciences products, CRO research services and procurement solutions for researchers across Europe
Highlights
- New on EvolcAdded 2026-10-30
About Tebu Bio
Tebubio distributes biological research products, including cells, antibodies, proteins, assays, chemicals and nucleic acids. It also provides contract research services in RNA-based therapeutic discovery, in vitro modeling, biomarker mapping and data analysis.
Its customers include life sciences and biotechnology researchers. Products are available through local offices and e-commerce, alongside procurement and compliance support.
Founded in 1974, Tebubio is headquartered in Le Perray-en-Yvelines, France, and operates from nine European sites. Its mRNA platform receives support through the French government's France 2030 plan.
Product: Biological research products, CRO laboratory services and procurement solutions for life sciences research.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France, worth €50.0M as awarded. From EU award notices (TED) that name Tebu Bio by its registry number.
- 18 Nov 2024 UNIVERSITE DE LILLE · Fourniture de produits, réactifs, consommables et petits matériels de laboratoire · €50.0M notice
Jobs at Tebu Bio
Leadership
- Donald van Dijk · Chief Executive OfficerSource: company website
- Baptiste van Dijk · Chief Operating OfficerSource: company website
- Jean François Têtu · Chief Product OfficerSource: company website
- Julien Gaboriau · Chief Information OfficerSource: company website
- Nathalie Alland · Chief Financial OfficerSource: company website
More biotech & pharma companies
Tedis
Pharmaceutical wholesale distributor linking laboratories with pharmacies and hospitals in France and export markets in Africa and AsiaSalary transparentTerratis
Sterile-insect mosquito control services for French municipalities and other high-traffic public areasYoung companyNew on EvolcThea Open Innovation
Ophthalmology innovation partnerships and investment for startups, researchers and companies developing eye-care treatmentsNew on EvolcTheravectys
Lentiviral vector vaccine candidates for cancers and chronic infectious diseases, developed with Institut PasteurNew on EvolcTissium
Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical useNew on EvolcTranscure Bioservices
Preclinical CRO running humanized and conventional mouse model studies for drug developers in oncology, inflammation and infectious diseaseNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Fastly
- Google Tag Manager
- Google reCAPTCHA
- LiveChat
- Magento
- New Relic
- Tailwind CSS